Related Experiment Video
Updated: Sep 23, 2025
22:10
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13.4K
What are the challenges with multi-targeted drug design for complex diseases?
Agata Zięba1, Piotr Stępnicki1, Dariusz Matosiuk1
1Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy, Medical University of Lublin, Lublin, Poland.
Expert Opinion on Drug Discovery
|May 13, 2022
Summary
Multi-target drugs offer a more effective approach for complex diseases than single-target drugs. Designing these drugs involves careful target selection and balancing affinities, with computational methods aiding the process.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Computational Drug Design
Background:
- Multifactorial diseases necessitate advanced therapeutic strategies beyond single-target interventions.
- Current research highlights the superior efficacy of multi-target drugs in managing complex pathologies.
Purpose of the Study:
- To review the application of multi-target drugs for complex diseases like neurodegenerative disorders, schizophrenia, diabetes, and cancer.
- To discuss challenges and strategies in designing multi-target ligands, including target selection and affinity balancing.
Main Methods:
- Exploration of in silico methodologies for multi-target ligand design and optimization.
- Review of computational approaches such as inverse docking, pharmacophore modeling, and network pharmacology.
Main Results:
- Successful examples of multi-target ligand design for prevalent complex diseases are presented.
- In silico methods are identified as crucial tools for overcoming design challenges.
Conclusions:
- Despite inherent complexities, the development of multi-target ligands is a worthwhile endeavor.
- Key factors for successful multi-target drug design include judicious target selection, balanced activity profiles, and optimized ligand drug-likeness.
Related Concept Videos
01:26Targets for Drug Action: Overview
7.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.6K
01:28Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
01:26Drug Discovery: Overview
8.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.9K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:24Principles of Drug Action
6.8K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.8K